SEC18 gene function is required for secretory protein transport between the endoplasmic reticulum (ER) and the Golgi complex. We cloned the SEC18 gene by complementation of the secl8-1 mutation. Gene disruption has shown that SEC18 is essential for yeast cell growth. Sequence analysis of the gene revealed a 2,271-base-pair open reading frame which could code for a protein of 83.9 kilodaltons. The predicted protein sequence showed no significant similarity to other known protein sequences. In vitro transcription and translation of SEC18 led to the synthesis of two proteins of approximately 84 and 82 kilodaltons. Antisera raised against a Secl8-0I-galactosidase fusion protein also detected two proteins (collectively referred to as Secl8p) in extracts of 35S-labeled yeast cells identical in size to those seen by in vitro translation. Mapping of the 5' end of the SEC18 mRNA revealed only one major start site for transcription, which indicates that the multiple forms of Secl8p do not arise from mRNAs with different 5' ends. Results of pulse-chase experiments indicated that the two forms of Secl8p are not the result of posttranslational processing. We suggest that translation initiating at different in-frame AUG start codons is likely to account for the presence of two forms of Secl8p. Hydrophobicity analysis indicated that the proteins were hydrophilic in nature and lacked any region that would be predicted to serve as a signal sequence or transmembrane anchor. Although potential sites for N-linked glycosylation were present in the Secl8p sequence, the sizes of the in vivo SEC18 gene products were unaffected by the drug tunicamycin, indicating that Secl8p does not enter the secretory pathway. These results suggest that Secl8p resides in the cell cytoplasm. While preliminary cell fractionation studies showed that Secl8p is not associated with the ER or Golgi complex, association with a 100,000 x g pellet fraction was observed. This suggests that Secl8p may bind transiently to small vesicles such as those presumed to participate in secretory protein transport between ER and the Golgi complex.
SEC18 gene function is required for secretory protein transport between the endoplasmic reticulum (ER) and the Golgi complex. We cloned the SEC18 gene by complementation of the secl8-1 mutation. Gene disruption has shown that SEC18 is essential for yeast cell growth. Sequence analysis of the gene revealed a 2,271-base-pair open reading frame which could code for a protein of 83.9 kilodaltons. The predicted protein sequence showed no significant similarity to other known protein sequences. In vitro transcription and translation of SEC18 led to the synthesis of two proteins of approximately 84 and 82 kilodaltons. Antisera raised against a Secl8-0I-galactosidase fusion protein also detected two proteins (collectively referred to as Secl8p) in extracts of 35S-labeled yeast cells identical in size to those seen by in vitro translation. Mapping of the 5' end of the SEC18 mRNA revealed only one major start site for transcription, which indicates that the multiple forms of Secl8p do not arise from mRNAs with different 5' ends. Results of pulse-chase experiments indicated that the two forms of Secl8p are not the result of posttranslational processing. We suggest that translation initiating at different in-frame AUG start codons is likely to account for the presence of two forms of Secl8p. Hydrophobicity analysis indicated that the proteins were hydrophilic in nature and lacked any region that would be predicted to serve as a signal sequence or transmembrane anchor. Although potential sites for N-linked glycosylation were present in the Secl8p sequence, the sizes of the in vivo SEC18 gene products were unaffected by the drug tunicamycin, indicating that Secl8p does not enter the secretory pathway. These results suggest that Secl8p resides in the cell cytoplasm. While preliminary cell fractionation studies showed that Secl8p is not associated with the ER or Golgi complex, association with a 100,000 x g pellet fraction was observed. This suggests that Secl8p may bind transiently to small vesicles such as those presumed to participate in secretory protein transport between ER and the Golgi complex.
The temperature-conditional yeast sec mutants define a set of functions required for secretory protein transport (20, 25) . Nine sec genes, including secl8, have been shown to cause a block in the transport of secretory proteins between the yeast endoplasmic reticulum (ER) and the Golgi complex (7, 19) . In secl8-1 mutant yeast cells, secretory protein traffic is blocked at the level of the ER on a shift to the nonpermissive growth temperature (37°C). This is true for both secreted enzymes, such as invertase, and vacuolar proteases, like carboxypeptidase Y (CPY), which use the secretory pathway for intracellular localization (28) . In sec18 mutant cells, ER function per se is not impaired. Protein translocation across the ER membrane continues at the nonpermissive temperature, as do secretory protein processing activities such as signal sequence cleavage and core oligosaccharide addition. However, protein modifications characteristic of the Golgi complex, such as the addition of outer chain mannose residues, are not observed on the accumulated secretory proteins (7, 19) . Electron microscopy has shown that secl8 mutant cells accumulate exaggerated forms of the ER (19, 25) . When secl8 mutant cells are returned to the permissive temperature (230C), accumulated secretory proteins undergo transport and processing through the remainder of the secretory pathway (20) . Accumulated invertase is released at the cell surface as the normal, active, highly glycosylated enzyme. Together, the specificity of the secl8-1 defect as well as its reversibility indicate that the secl8 mutant accumulates an authentic intermediate in the protein secretion pathway. Because interorganelle traffic between secretory compartments likely occurs via vesicle carriers, the SEC18 gene is presumed to encode a function that is involved in either the selective packaging of secretory proteins into carrier vesicles or the transport and fusion of such vesicles with the correct Golgi complex target membrane.
We report the cloning and sequencing of the SEC18 gene. In addition, we characterized both the mRNA and two protein products (referred to collectively as Secl8p) encoded by this gene. Together, our observations suggest that Secl8p acts on the vesicle carriers that shuttle membrane and protein between ER and Golgi complex compartments.
MATERIALS AND METHODS Strains. Escherichia coli Mc1061 [F-araD139
A(araABOIC-leu)7679 AlacX74 galU galK rpsL hsdR] (3) was used for cloning and fusion protein production, and JM101 was used for M13 phage growth for sequencing. Saccharomyces cerevisiae strains used were SEY2101 (MATa ura3-52 leu2-3,112 suc2-A9 ade2-1) (6), SEY5186 (MATot secUl8-1 ura3-52 leu2-3,112) (5), and SEY6201 (MATa ira3-52 leu2-3,112 his3-A200 trpl-A901 suc2-A9 ade2-101) (this study). Strains were grown in standard medium preparations (16, 27) .
Materials. Restriction enzymes, T4 DNA ligase, Bal 31 nuclease, mung bean nuclease, and 5-bromo-4-chloro-3-gift from T. Silhavy. Antiserum against the P subunit of mitochondrial F1-ATPase was a gift from M. Douglas. Antiserum against CPY was from Klionsky et al. (10) .
Recombinant DNA constructions. Preparation of DNA, restriction digestions, agarose gel electrophoresis, and cloning of DNA fragments were done as described previously (14) .
DNA sequencing. DNA sequencing was done by standard dideoxy chain termination methods (24) by using Bal 31 deletion subclones of SEC18 in M13mpl9. DNA and protein sequences were compiled and analyzed with computer programs written by K. Eakle (unpublished data). Homology searches of the National Biomedical Research Foundation Protein Identification Resource data base were done on BIONET by using the XFASTP program (13) .
Antisera production. SEC18-lacZ fusions were generated by cloning Bal 31 nuclease digestions of the 3.0-kilobase (kb) BamHI-HindIII fragment into SmaI-cut pORF5. Clones were screened for overproduction of P-galactosidase activity on ampicillin-containing plates with Xgal. Plasmid DNA was prepared from candidate clones and checked for SEC18 inserts by restriction mapping. Whole-cell extracts of E. coli with candidate plasmids were run on SDS-polyacrylamide gels (11) and evaluated by both Western blotting (30) with primary antisera against P-galactosidase (visualized by the HRP color reaction system) and staining with Coomassie blue to identify fusion protein bands and to estimate the extent of overproduction.
Fusion proteins were purified by growing E. coli with the fusion construction pORF18-40 to the stationary phase.
Cells (250 OD6. units; 1 OD6. unit of cells equals the cells in 1 ml of a culture grown to an optical density at 600 nm of 1.0) were pelleted and suspended at 10 OD6. units per ml in 50 mM Tris (pH 8.0)-10 mM EDTA-10 mM dithiothreitol. Cells were lysed with a French press and spun at 6,000 x g for 20 min at 4°C in a rotor , and the supernatant was spun at 170,000 x g for 30 min at 15°C in a rotor (Ti7O.1). Membrane pellets were suspended in a small volume of buffer, and samples of the fractions were assayed forgalactosidase activity at appropriate dilutions (16) . Greater than 50%o of the total P-galactosidase activity of the fusion proteins was associated with the membrane pellet, which yielded the equivalent of 2 to 3 mg of P-galactosidase activity. The largest fusion band was fragment purified from 5% SDS-polyacrylamide preparative gels that were stained with Coomassie blue. Commercially available P-galactosidase was also run on the preparative gels and was used to estimate the amount of fusion protein recovered. Fusion bands were homogenized, dialyzed against phosphate-buff- (12) . The reaction mixture was diluted with 400 p.1 of 50 mM sodium acetate (pH 5.0)-10 mM NaCI-1 mM ZnSO4 and digested with 50 U of mung bean nuclease for 1 h at 37°C (8) . The reaction was phenol extracted twice and ethanol precipitated with glycogen as a carrier. To identify the size of the digestion products of the hybridization reaction, dideoxy sequencing reactions were carried out with the 32P-endlabeled oligonucleotide as the primer and label in the reactions. The sequencing reactions and the digestion products of the hybridization reaction were run on a 6% sequencing gel.
Mapping at the 3' end was performed as described above for the mapping of the 5' end. In vitro transcription and translation. Yeast in vitro translation extracts were prepared as described previously (31) and treated with micrococcal nuclease. RNA was generated by SP6 RNA polymerase runoff transcription of the minimum complementing subclone of SEC18 cloned in pSP65, using ribonucleotide mixes with and without 0.5 mM m7G(5')ppp(5')G to give a capped mRNA (15) . In vitro translation was performed as described previously (31) 13 ,000 x g for 15 min at 4°C. Supernatant (0.8 ml) from the microfuge spin was carefully removed and spun at 100,000 x g in a rotor (Ti70.1). Excess supematant was removed carefully from the microfuge pellet, which was suspended in 100 p.1 of SDS boiling buffer, and boiled for 3 min. The supernatant from the 100,000 x g spin was precipitated with trichloroacetic acid on ice for 20 min, and the 100,000 x g pellet was suspended in 100 p.1 of SDS boiling buffer and boiled for 3 min. Samples were immunoprecipitated as described above. RESULTS
Characterization and cloning of the SEC18 locus. The secl8-1 mutation in S. cerevisiae has been shown to cause a block in the transfer of proteins from the ER to the Golgi complex on a shift to the nonpermissive temperature. This block results in the accumulation of ER, as identified by thin-section electron microscopy (19, 20, 25 Analysis of SEC18 mRNA. Northern blots (Fig. 4A) with single-stranded probes from either strand of the SEC18 clone confirmed that the only transcript from this region of DNA was a poly(A)+, 2,500-nucleotide mRNA in the orientation of the open reading frame seen in the DNA sequence. End mapping experiments of the 5' end of the SEC18 transcript were done with a 32P-end-labeled single-stranded probe and mung bean nuclease (Fig. 4B) . Results of these experiments revealed that there is only one major initiation point for genomic transcription, beginning almost exactly at the position of the start of the smallest complementing subclone. This places our predicted TATA sequences within the transcribed region. Only the DNA which corresponded to the transcribed region appeared to be necessary for complementation of the secl8(Ts) defect. Because other single-and multicopy vectors were used to test complementation of this subclone, it seems unlikely that complementation was the addition of core oligosaccharides which could account for the multiple forms of the proteins that were produced. Transcription by SP6 RNA polymerase also has high fidelity in terms of the site of transcription initiation, so variation in the 5' end of the RNA template does not seem likely (15) .
In order to test whether the protein(s) produced from the SEC18 open reading frame was also produced in vivo, we raised antisera to the SEC18 protein. A gene fusion of the SEC18 open reading frame to the 5' end of the E. coli lacZ gene was generated by ligating random Bal 31 digestions of the 3.0-kb BamHI-HindIII fragment into the vector pORF5 (26) (Fig. 6A) . Clones which overproduced ,B-galactosidase activity were initially picked by screening on Xgal plates. Plasmids from these clones were screened for inserts corresponding to the SECl8 gene by restriction site analysis. In addition, SDS-PAGE of whole-cell E. coli extracts expressing high levels of P-galactosidase activity were stained with Coomassie blue to visualize the extent of overproduction and to identify the size of the hybrid proteins (Fig. 6B) . Western blotting of these gels with ,I-galactosidase-specific antibodies confirmed the identity of hybrid protein bands. Several gene fusions were created which overproduced fusion proteins in E. coli that were up to 40,000 daltons larger than P-galactosidase itself. The fusion joints between five of these clones and the lacZ sequences were determined by DNA sequencing, which confirmed that the large open reading frame of SEC18 was being used. The largest fusion protein was purified by using preparative SDS-PAGE and was injected into rabbits to raise antiserum that was reactive to Secl8p. Antisera were tested initially for reaction to the Secl8-3-galactosidase fusion protein on Western blots and were later confirmed to react with the in vitro translation products of SEC18.
Immunoprecipitation from extracts of 35S-labeled whole yeast cells with the Secl8p antiserum was able to detect in Bal 31 digestions of the 3.0-kb BamHI-HindIII fragment were cloned into the SmaI site of pORF5, a lacZ fusion vector in which a EcoRISmaI-BamHI polylinker was inserted at the amino acid at position 7 to interrupt the reading frame of the lacZ gene. The fragment marked with double asterisks is clone pORF18-40, which expressed the largest fusion protein observed. Restriction enzyme abbreviations: B, BamHI; P, PstI; K, KpnI; Hp, HpaI; H, Hindlll. (B) Whole-cell extracts of E. coli MclO61, with and without the pORF18-40 fusion plasmid, were run on SDS-polyacrylamide gels. A gel stained with Coomassie blue G-250 is shown on the left, and on the right is a Western blot of a gel identical to that shown on the left whose proteins were transferred to nitrocellulose by Western blot and probed with anti-f3-galactosidase antisera. The largest fusion protein is marked with double asterisks. kd, Kilodaltons. vivo production of the putative SEC18 gene products. The in vivo forms of Secl8p were identical in size to those seen by in vitro translation (Fig. 5) . Tunicamycin, which inhibits N-linked glycosylation, had no effect on the size of the in vivo proteins that were observed, even though potential sites for glycosylation were present in the predicted amino acid sequence at amino acid positions 13, 36, 455, 474, and 689. This suggests that Secl8p is not translocated across the ER membrane into the secretory pathway, and thus, it never comes into contact with the oligosaccharide transferase enzyme. This was further supported by the hydrophobicity profile for the predicted Secl8p sequence (Fig. 7) , which showed no evidence for a characteristic hydrophobic signal sequence at the amino terminus of either the full-length protein or a protein whose translation began at one of the two downstream ATG codons at the 5' end of the open reading frame. In addition, the hydrophobicity profile did not show any internal regions which would be predicted to span a membrane or function as internal signal sequences. These data are most consistent with the fact that Secl8p remained in the cell cytoplasm. However, these results do not exclude the association of Secl8p with the cytoplasmic face of an intracellular organelle membrane.
The two forms of Secl8p seen in vivo also could have resulted from a posttranslational processing event other than glycosylation. To address this question, yeast cells were pulse-labeled for 20 min with 3"SO4 and chased for various times following the addition of excess cold S04. Whole-cell extracts were immunoprecipitated with antisera directed against both Secl8p and CPY, a vacuolar protease which undergoes processing in the ER, Golgi complex, and vacuole to give forms which can be distinguished on SDS-polyacrylamide gels (28) . The results (Fig. 8) indicated that while CPY is processed normally with a half-time of approximately 5 min, the two forms of Secl8p are maintained in a constant ratio. This was true for chase periods of up to 2 h (data not shown). Thus, the two forms of Secl8p do not appear to result from posttranslational processing of the larger form into the smaller form or vice versa. It appears that messages containing the entire open reading frame lead directly to the production of two forms of the same protein. It is reasonable to propose that the two forms arise from translation that is initiated at different points in the open reading frame of the mRNA.
Results of this study indicate that Secl8p represents a relatively minor fraction total protein production in yeast cells. From quantitation of the relative levels of production of Secl8p and CPY by densitometry, we estimate that Secl8p is produced at only 1/5th to 1/10th of the level of CPY. Twentyfold overproduction of Secl8p was observed in cells harboring the SEC18 gene on a multicopy plasmid (pSEY8). This suggests that SecJ8 is expressed constitutively and is subject to simple gene dosage control. Experiments looking at the production of Secl8p from the mutant sec18-J(Ts) allele show that the temperature-sensitive defect does not result from a decrease in Secl8p expression. In addition, the temperature-sensitive forms of the protein appear to show the same stability at the nonpermissive temperature as wild-type proteins do in pulse-chase labeling experiments (data not shown).
Intracellular location of Secl8p. Our data predict that Secl8p is probably a cytoplasmic protein. To determine this directly, we used cell fractionation techniques with differential centrifugations to separate yeast cells into membraneenclosed and cytoplasmic compartments. Because of its role in transport between the ER and Golgi complex, we were especially interested to see whether Secl8p might be associated with these compartments. A procedure giving gentle osmotic lysis was developed which appeared to maintain the integrity of small organelles such as mitochondria, ER, and the Golgi complex. Cells were spheroplasted extensively before they were labeled, and then they were washed and labeled with Trans35S label in the presence of full osmotic support (1.2 M sorbitol). To lyse the cells osmotically, cells were pelleted gently, suspended in a small volume of buffer with full osmotic support, and then quickly diluted in a buffer with partial osmotic support (0.25 M sucrose). After an initial low-speed spin to pellet any unlysed cells, the cleared lysate was centrifuged sequentially in a microfuge (13,000 x g for 15 min) and a ultracentrifuge (100,000 x g for 30 min). markers for the ER, Golgi complex, and vacuolar compartments (28) . Immunoprecipitation with antisera against the P-subunit of mitochondrial Fl-ATPase was also done to assess the fractionation and intactness of mitochondria in this procedure. Figure 9 shows an autoradiograph of immunoprecipitates of CPY and Secl8p from such an experiment, which is quantitated in Table 1 . The pl and p2 forms of CPY, which should be localized within the ER and Golgi complex, respectively, were mainly present (80%) in the 13,000 x g pellet. A small amount of pl and p2 (20%) was found in the 100,000 x g pellet fraction, perhaps because of some fragmentation of these compartments or the material present in small vesicles in transit between secretory organelles.
Greater than 95% of the P-subunit of mitochondrial FlATPase was also pelleted in a microfuge. These results indicate that organelles such as ER, Golgi complex, and mitochondria appear to remain largely intact by this lysis procedure and are recovered predominantly in the 13,000 x g pellet. In contrast, lysis of whole cells by a more vigorous procedure (vortexing in the presence of glass beads) led to 60 to 80% release of the ER, Golgi complex, and mitochondrial markers into the supernatant fraction (data not shown). Very little (<5%) of the mature CPY, a protease that is present in the lumen of the yeast vacuole, was associated with the 13,000 x g pellet fraction. The yeast vacuole is a very fragile compartment which we would expect to be lysed without full osmotic support. This was confirmed by the presence of mature CPY predominantly (>95%) in the 100,000 x g supernatant fraction.
Secl8p was found in significant amounts in both the 100,000 x g pellet (44%) and supernatant (56%) fractions. Little (<1%), if any, of Secl8p was associated with the microfuge pellet fraction. Since Secl8 is implicated in transport between the ER and the Golgi complex, it is somewhat surprising that it would be found in a high-speed pellet fraction in which small vesicles would presumably be recovered and yet not be associated with a fraction (the 13,000 x g pellet) in which the bulk of the ER and the Golgi complex DISCUSSION As a first step in understanding the role of the yeast SEC18 gene product in secretory protein transport between the ER and the Golgi complex, we cloned and sequenced the gene. A single 3.0-kb DNA fragment was isolated that complemented the temperature-sensitive defect exhibited by sec18-I mutant yeast cells. This DNA segment mapped genetically to the SEC18 locus. RNA probes derived from the cloned segment detected one major 2,500-nucleotide poly(A)+ mRNA on Northern blots (Fig. 4A) . Consistent with this, the major open reading frame (2,271 bp) in the SEC18 clone was predicted to encode a protein of 84 kilodaltons. Somewhat surprisingly, two protein products of this open reading frame were observed both from in vitro translation extracts programmed with SEC18 mRNA and from in vivo 35S-labeled yeast cell extracts (Fig. 5) . Disruption of this open reading frame indicates that the function of Secl8p is essential for cell viability. Spores containing a disrupted SEC18 gene were able to germinate but only underwent, at most, one round of cell division in the absence of SEC18 expression.
Several aspects of SEC18 gene expression were novel and unexpected. First, sequences upstream from the site of transcription initiation did not appear to be necessary for SEC18 expression. A subclone which contained only five nucleotides preceding the start point of transcription was sufficient for the expression of adequate levels of Secl8p for the complementation of the secl8-1 mutation. Complementation with this subclone was observed when several different high-and low-copy-number yeast shuttle vectors were used, suggesting that aberrant expression of this subclone in a particular plasmid context is not the cause of the observed complementation.
Second, there were two sequences just upstream of the open reading frame, TATATT at bases 516 to 522 and TATAAA at 529 to 535, which could possibly function as TATA elements for transcriptional control. Yet, these sequences were actually within the transcribed region itself rather than at the normal position that TATA elements usually occupy 40 to 120 bp 5' of the site of transcription initiation (29) . This, along with the fact that the transcribed region alone appeared to be sufficient for gene expression, raises the possibility that SEC18 promoter elements may function from within the gene itself. Alternatively, these 116kd-97 kdSec18p _6 8 kd-40 kd-VOL. 8, 1988 TATA elements formed part of a cryptic promoter leading to expression of the minimum complementing fragment.
Third, the SEC18 gene produced two proteins from transcripts that appeared to start at a single site. Other cases of the expression of multiple forms of protein from a single yeast gene have been observed, such as the production of cytoplasmic and secreted forms of invertase from the yeast SUC2 gene (2) . However, these were caused by multiple sites of transcription initiation leading to messages which had different AUG codons of the open reading frame at their 5' ends. There is a precedent for translation initiating at multiple AUG codons in a yeast mRNA. The GCN4 gene of S. cerevisiae, whose protein product controls the transcription of a large number of amino acid biosynthesis genes, uses translation initiation at multiple AUG codons in the mRNA as a translational control of its expression (17) . Four short open reading frames of an AUG codon followed by two to three codons are present in an -600 nucleotide leader region of the GCN4 mRNA and act to inhibit the translation of GCN4 under nonstarvation conditions (17) . In contrast, SEC18 appeared to have only one major class of mRNA with a short 5'-untranslated leader and a set of three AUG codons early in the mRNA that were all in frame with the major open reading frame of the gene, yet two forms of the same protein with different sizes were produced (Fig. 4 and 5) . The two forms of the protein did not appear to be the result of posttranslational processing events (Fig. 8) . The size of the smaller protein product corresponded well to the predicted size of translation products initiated from AUGs that were 19 or 21 codons downstream of the first AUG codon of the open reading frame, leading us to suggest that the smaller protein product arises from translation initiating at one of these downstream codons. In vitro mutagenesis of the different AUG codons in SEC18 should reveal whether translation indeed starts at more than one site or whether another mechanism is responsible for the multiple forms of protein being produced. In addition, such in vitro mutagenesis should permit one to test whether the two Secl8 proteins are functionally equivalent. It is tempting to speculate that the two isoforms of Secl8p could have different functional roles in directing secretory protein traffic.
The intracellular location of Secl8p was analyzed to gain insight into the functional role that Secl8 plays in the secretory pathway. The predicted amino acid sequences of Secl8 proteins did not indicate any targeting signal which would allow Secl8p to be translocated across the ER membrane. The conclusion that Secl8p remains in the cytoplasm was reinforced by the observation that Secl8p was not modified with core oligosaccharides (Fig. 5) , a function which is carried out within the ER, even though potential sites for N-linked glycosylation are present in the amino acid sequence. Results of cellular fractionation experiments by an osmotic lysis procedure, which was able to maintain the integrity of organelles such as mitochondria, ER, and the Golgi complex, indicated that Secl8p is not tightly associated with the bulk of ER or the Golgi complex (Fig. 9) . However, centrifugation at higher g forces revealed a distribution of Secl8p between the pellet and soluble fractions. This observation suggests that Secl8p may be associated with small vesicles or a macromolecular complex that is important in intracellular secretory protein transport.
The phenotype of secl8-1 mutant yeast cells suggests a direct role for Secl8p in the transport of secretory proteins between the ER and the Golgi complex. At the nonpermissive temperature, there was a rapid accumulation of newly synthesized secretory proteins which underwent all of the modifications characteristic of the ER (signal sequence cleavage and addition of core oligosaccharides). No modification or processing events known to occur after that of the ER were observed in the secl8-1 mutant. Therefore, it appears that a block exists in the transfer of secretory proteins from the ER to the Golgi complex. Possible functions for Secl8p might include the packaging of proteins into transport vesicles, a role in the budding of such vesicles, the transport of vesicles to the target organelle, recognition or fusion of these vesicles with the Golgi complex, or the recycling of transport components back to the ER. The cytoplasmic location of Secl8p rules out any direct role in the sorting and selection of proteins from the lumen of the ER for transport to the Golgi complex. Our data, which show an association of Secl8p with a high-speed pellet fraction, suggest that Secl8p may function in the formation of small transport vesicles at the ER or in their transport and targeting to Golgi complex membranes. The recent development of efficient in vitro transport assays for ER to Golgi complex protein traffic (1) may provide a means to examine directly the functional role of Secl8p in this critical interorganelle transport event, potentially in both yeast and mammalian reconstituted systems.
